News tagged with 'Anemia Drugs'

Just days after European health regulators announced they were considering a ban on use of the anemia drug Eprex in patients with chronic kidney failure due to its link to pure red cell aplasia (PRCA), Janssen-Cilag, a European subsidiary of Johnson & Johnson, said it will change the prescribing information of the medi

European health regulators are considering banning the use of the anemia drug Eprex in patients with chronic kidney failure due to an increasing number of reports that the medication may cause pure red cell aplasia (PRCA), a condition characterized by a near absence of red blood cell precursors that leaves many suffere

Johnson and Johnson announced Thursday that it has received 160 reports of pure red-cell aplasia (PRCA) among users of the anemia drug Eprex (erythropoietin). Eprex's link to PRCA, a condition characterized by a near absence of red blood cell precursors that leaves many patients dependent on transfusions to survive, h

Johnson & Johnson announced Thursday that it has received over 100 reports of pure red cell aplasia (PRCA) in patients taking the anemia drug Eprex (erythropoietin). The announcement comes one month after the U.S. Food and Drug Administration (FDA) officially confirmed the drug's link to the disorder in a letter publi

Officials with the U.S. Food and Drug Administration (FDA) officially confirmed the anemia drug Eprex's link to pure red cell aplasia (PRCA) in a letter published in this week's issue of The New England Journal of Medicine. Eprex's link to PRCA, a condition characterized by a near absence of red blood cell precursors,

Concerns over Johnson & Johnson's anti-anemia drug, Eprex, were renewed this week after a report in the New England Journal of Medicine confirmed that the medication is linked to a recent increase in pure red cell aplasia (PRCA) cases. PRCA is a condition characterized by a near absence of red blood cell precursors.

Johnson & Johnson's stock dropped two percent this week after the company announced that its anemia drug, Eprex, known in the U.S. as Procrit, may be linked to 40 confirmed cases of pure red cell aplasia (PRCA), a condition characterized by a near absence of red blood cell precursors. The company revealed that it